Resource library

Scientific publications

Scientific publications

Quantitative imaging biomarker of disease progression in hepatocellular carcinoma and NASH

Nakano Y, Oubel E, Brag J, Doreille A, Lucidarme O.    The feasibility of using routine CT imaging protocols, combined with big data processing for extracting radio-logical signatures, for assessing disease progression in NASH patients.  Poster presentation at: The NASH Biomarker Workshop 2017

Analysis of spleen volumetry as imaging biomarker: Precision of measurements and usability on CT and MRI

Beaumont H, Oubel E, Iannessi A, Thyss P.A. Analysis of spleen volumetry as imaging biomarker: Precision of measurements and usability on CT and MRI. Poster presentation at: ECR 2016.

Modified RECIST for monitoring hepatocellular carcinoma with computed tomography: Inter-reader variability of the response

Beaumont H, Egels  S, Iannessi A, Bonnard E, Foley C, Lucidarme O. Modified RECIST for monitoring hepatocellular carcinoma with computed tomography: Inter-reader variability of the response. Poster presentation at: AACR 2016.

Reliability of Apparent Diffusion Coefficient assessments according to the QIBA guidelines

Beaumont H, Moreau B, Hoog C, Oubel E, Iannessi A. Reliability of Apparent Diffusion Coefficient assessments according to the QIBA guidelines. Poster presentation at: ESMO 2016

The detection of new lesions as a major factor of local investigator-central review discrepancy during a RECIST phase II trial

Beaumont H, Evans T.L, Hong S.R, Chadjaa M, Monostori Zs. The detection of new lesions as a major factor of local investigator-central review discrepancy during a RECIST phase II trial. Poster discussion presented at ESMO Asia 2015

Resource library

Cookies help us deliver our services. By using our services, you agree to our use of cookies.